[Asia Economy Reporter Lee Seon-ae]



▲Celltrion=Applied for domestic approval of Avastin biosimilar with the Ministry of Food and Drug Safety


▲Samsung Biologics=Signed a letter of intent for a contract worth 49.1 billion KRW with MSD for contract manufacturing of biopharmaceuticals


▲Zico=Changed CEO from Kim Hyung-cheol to Jung Byung-soo


▲ANP=Decided to issue convertible bonds worth 3 billion KRW


▲GS Construction=Won a contract worth 252.1 billion KRW from SCI for apartment construction on the Gwangju Honam University Ssangchon Campus site


▲Sejin Heavy Industries=Decided to acquire 4 billion KRW worth of shares in Dongbang Seon-gi to diversify business


▲SKC=Decided to dispose of treasury shares worth 19.6 billion KRW to motivate employees of headquarters and subsidiaries


▲SD Biosensor=Acquired 20 billion KRW worth of shares in UXN, a manufacturer of blood glucose meters



▲Wooridle Hubrain=Acquired 17 billion KRW worth of shares in Infomark, a 5G communication device specialist company


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing